MTC Versus FMT in for RCDI

Comparison of MTC01 vs FMT for the Treatment of Recurrent Clostridioides Difficile Infection

NCT05911997•Icahn School of Medicine at Mount Sinai

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Clostridiodies Difficile Infections

Interventions

MTC 01

Fecal Microbiota Transplantation (FMT)

Locations

United States

Locations (1)

Icahn School of Medicine at Mount Sinai

New York, New York, United States

Key Dates

Start Date

January 8, 2024

Primary Completion Date

July 25, 2026

Completion Date

July 25, 2026

Last Updated

November 10, 2025

Contacts

Sari Feldman, MS

CONTACT

212-824-7669 sari.feldman@mssm.edu

Sponsors

Lead Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 10, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions